New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 ...
Medtronic (MDT) announced FDA clearance for its new InPen app featuring missed meal dose detection, paving the way for the launch of its Smart MDI system with the Simplera continuous glucose monitor, ...
Hosted on MSN
MDT Stock Gains From FDA Approval for Its InPen App
Medtronic plc MDT recently received Food and Drug Administration (“FDA”) clearance for its new InPen app, which features missed meal dose detection. This latest FDA clearance should pave the way for ...
Medtronic disclosed that its Smart MDI system with continuous glucose monitoring capabilities is closer to launching after the Food and Drug Administration cleared an associated app. The medical ...
DUBLIN, June 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced key clinical data from the virtual 81st annual American Diabetes Association ...
Just a few months after Medtronic resolved a late 2021 FDA warning letter describing quality control issues at the headquarters of its diabetes division, that segment of its business is in the hot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback